Robb Knie

Robb Knie is a declared insider of Hoth Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 16 September 2022 and 28 August 2025, the trades on record add up to 5 filings.

Purchases make up the whole of the open-market record (3 purchases, €23k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants.

Half of the purchases are above €4,005 and half below. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The newest entry dates from 28 August 2025: a share grant of €322k, in Hoth Therapeutics, Inc. The most recent open-market purchase was published on 19 August 2024, 811 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.